Top 5 Reasons Apple (AAPL) is Selling Off
Tweet Send to a Friend
Get Alerts AAPL Hot Sheet
Price: $441.35 --0%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.7%
Revenue Growth %: +11.2%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.7%
Revenue Growth %: +11.2%
Trade AAPL Now!
Apple (Nasdaq: AAPL) has been selling-off the past five sessions faster than anything witnessed in the stock in at least six months. The dramatic fall has investors asking why.
Here are the top 5 likely reasons:
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Here are the top 5 likely reasons:
- Profit taking- With shares up 58% YTD the stock has become a source of funds for taxes or other investments.
- Earnings expectations are too high- Apple reports Q2 results on 4/24 and Street estimates have been creeping higher into the report. When analysts get too optimistic there is a fear that the company could disappoint. The Q2 consensus is $9.89, versus the company's guidance of $8.50.
- Hedge fund rotation out of the stock- Apple has been a hedge fund hotel. It is said that popular hedgie Dan Loeb of Third Point Capital sold all of his position and maybe a lot of his buddies too.
- Subsidy cuts- There is a growing sense that the carriers will take some power back after coughing up $700 per iPhone then selling them for $200 and eating the difference. Apple warned about the risk of this in the past.
- Index rotation - While not likely, there is talk that Texas Instruments' (NYSE: TXN) addition into the Nasdaq 100 could force some selling of Apple to make room.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Short Sellers See the Light (HLF) (FSLR) (NFLX) (TLSA)
- UPDATE: Cubist Pharmaceuticals (CBST) Spikes to Session Highs
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkRelated Entities
Daniel Loeb, Third Point LLC, Hedge Funds, EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

